- INTRODUCTION
- STUDY OBJECTIVES
- MARKET DEFINITION
- INCLUSIONS AND EXCLUSIONS
- MARKET SCOPE
- MARKETS COVERED
- YEARS CONSIDERED
- CURRENCY CONSIDERED
- STAKEHOLDERS
- RESEARCH LIMITATIONS
- SUMMARY OF CHANGES
- RECESSION IMPACT
- RESEARCH METHODOLOGY
- RESEARCH DATA
- SECONDARY DATA
- PRIMARY DATA
- MARKET SIZE ESTIMATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH: PENETRATION RATE-BASED MARKET SIZE ESTIMATION
- GROWTH FORECAST
- Table IMPACT ANALYSIS
- MARKET BREAKDOWN AND DATA TRIANGULATION
- ASSUMPTIONS
- RISK ASSESSMENT
- RESEARCH DATA
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- DIGITAL THERAPEUTICS MARKET OVERVIEW
- DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2023 VS. 2O28
- DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- MARKET OVERVIEW
- INTRODUCTION
- MARKET DYNAMICS
- DRIVERS
- RESTRAINTS
- OPPORTUNITIES
- CHALLENGES
- INDUSTRY TRENDS
- VIRTUAL REALITY
- RISING DEMAND FOR DIGITAL SOLUTIONS IN CBT
- TECHNOLOGY ANALYSIS
- Table TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES
- MACHINE LEARNING
- ARTIFICIAL INTELLIGENCE
- INTERNET OF THINGS
- BLOCKCHAIN TECHNOLOGY
- CLOUD COMPUTING
- DATA ANALYTICS
- EXTENDED REALITY
- VALUE CHAIN ANALYSIS
- RESEARCH & PRODUCT DEVELOPMENT
- MATERIAL COMPONENTS
- MANUFACTURERS & DEVELOPERS
- DISTRIBUTION & SALES
- END-USER INDUSTRIES
- POST-SALE SERVICES
- ECOSYSTEM ANALYSIS
- PIPELINE PRODUCTS
- CASE STUDY ANALYSIS
- CASE STUDY 1: WELLTHY THERAPEUTICS (INDIA)
- CASE STUDY 2: HAPPIFY HEALTH (US)
- CASE STUDY 3: OMADA HEALTH (US)
- PORTER’S FIVE FORCES ANALYSIS
- THREAT OF NEW ENTRANTS
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF BUYERS
- THREAT OF SUBSTITUTES
- INTENSITY OF COMPETITIVE RIVALRY
- REGULATORY LANDSCAPE
- REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- Table NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- Table EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- Table ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- Table REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- Table DIGITAL THERAPEUTICS MARKET: REGULATORY DATA NEEDED FOR CLASS II DEVICES
- REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- PRICING ANALYSIS
- COSTS INVOLVED IN DIGITAL THERAPEUTICS
- INDICATIVE PRICING ANALYSIS, BY KEY PLAYER & COUNTRY
- Table AVERAGE SELLING PRICE OF DIGITAL THERAPEUTIC PRODUCTS, BY COUNTRY
- INDICATIVE PRICING ANALYSIS OF DIGITAL THERAPEUTICS, BY REGION
- REIMBURSEMENT SCENARIO
- Table DIGITAL THERAPEUTICS MARKET: GLOBAL COVERAGE DETERMINATION STANDARDS
- PATENT ANALYSIS
- PATENT PUBLICATION TRENDS
- INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- LIST OF MAJOR PATENTS
- Table KEY PATENTS IN DIGITAL THERAPEUTICS MARKET
- KEY CONFERENCES AND EVENTS
- Table DIGITAL THERAPEUTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
- KEY STAKEHOLDERS AND BUYING CRITERIA
- KEY STAKEHOLDERS IN BUYING PROCESS
- Table INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR SALES CHANNEL, BY RANKING
- BUYING CRITERIA
- Table KEY BUYING CRITERIA FOR SALES CHANNEL, BY RANKING
- KEY STAKEHOLDERS IN BUYING PROCESS
- REVENUE SHIFT AND NEW REVENUE POCKETS FOR DIGITAL THERAPEUTICS MARKET
- INVESTMENT LANDSCAPE
- DIGITAL THERAPEUTICS MARKET, BY OFFERING
- INTRODUCTION
- Table DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- SOFTWARE/PLATFORMS
- ABILITY TO PROVIDE SCALABLE SOLUTIONS FOR DEPLOYMENT TO PROPEL MARKET
- Table DIGITAL THERAPEUTICS MARKET FOR SOFTWARE/PLATFORMS, BY REGION, 2021-2028 (USD MILLION)
- ABILITY TO PROVIDE SCALABLE SOLUTIONS FOR DEPLOYMENT TO PROPEL MARKET
- PROGRAMS
- INTRODUCTION OF EVIDENCE-BASED THERAPEUTIC PROGRAMS TO SUPPORT MARKET GROWTH
- Table DIGITAL THERAPEUTICS MARKET FOR PROGRAMS, BY REGION, 2021-2028 (USD MILLION)
- INTRODUCTION OF EVIDENCE-BASED THERAPEUTIC PROGRAMS TO SUPPORT MARKET GROWTH
- VIRTUAL REALITY/GAMES
- RISING DEMAND FOR VR SOLUTIONS TO DRIVE MARKET
- Table DIGITAL THERAPEUTICS MARKET FOR VIRTUAL REALITY/GAMES, BY REGION, 2021-2028 (USD MILLION)
- RISING DEMAND FOR VR SOLUTIONS TO DRIVE MARKET
- INTRODUCTION
- DIGITAL THERAPEUTICS MARKET, BY APPLICATION
- INTRODUCTION
- Table DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- TREATMENT/CARE-RELATED APPLICATIONS
- Table DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
- DIABETES
- Table DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2021-2028 (USD MILLION)
- CENTRAL NERVOUS SYSTEM (CNS) DISORDERS
- Table DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY REGION, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR OTHER CNS DISORDERS, BY REGION, 2021-2028 (USD MILLION)
- SMOKING CESSATION
- Table DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2021-2028 (USD MILLION)
- CHRONIC RESPIRATORY DISEASES
- Table DIGITAL THERAPEUTICS MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2021-2028 (USD MILLION)
- MUSCULOSKELETAL DISORDERS
- Table DIGITAL THERAPEUTICS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
- CARDIOVASCULAR DISEASES
- Table DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021-2028 (USD MILLION)
- MEDICATION ADHERENCE
- Table DIGITAL THERAPEUTICS MARKET FOR MEDICATION ADHERENCE, BY REGION, 2021-2028 (USD MILLION)
- GASTROINTESTINAL DISORDERS
- Table DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
- REHABILITATION & PATIENT CARE
- Table DIGITAL THERAPEUTICS MARKET FOR REHABILITATION & PATIENT CARE, BY REGION, 2021-2028 (USD MILLION)
- SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT
- Table DIGITAL THERAPEUTICS MARKET FOR SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
- OTHER TREATMENT/CARE-RELATED APPLICATIONS
- Table DIGITAL THERAPEUTICS MARKET FOR OTHER TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
- PREVENTIVE APPLICATIONS
- Table DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
- PREDIABETES
- Table DIGITAL THERAPEUTICS MARKET FOR PREDIABETES, BY REGION, 2021-2028 (USD MILLION)
- OBESITY
- Table DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2021-2028 (USD MILLION)
- NUTRITION
- Table DIGITAL THERAPEUTICS MARKET FOR NUTRITION, BY REGION, 2021-2028 (USD MILLION)
- LIFESTYLE MANAGEMENT
- Table DIGITAL THERAPEUTICS MARKET FOR LIFESTYLE MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
- OTHER PREVENTIVE APPLICATIONS
- Table DIGITAL THERAPEUTICS MARKET FOR OTHER PREVENTIVE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
- INTRODUCTION
- DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL
- INTRODUCTION
- Table DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- SUBSCRIPTION-BASED MODEL
- FLEXIBILITY IN PAYMENT OPTIONS TO DRIVE MARKET
- Table DIGITAL THERAPEUTICS MARKET FOR SUBSCRIPTION-BASED MODEL, BY REGION, 2021-2028 (USD MILLION)
- FLEXIBILITY IN PAYMENT OPTIONS TO DRIVE MARKET
- ONE-TIME PURCHASE/ANNUAL LICENSING MODEL
- BENEFITS OF LIMITED RECURRING PAYMENTS TO BOOST DEMAND
- Table DIGITAL THERAPEUTICS MARKET FOR ONE-TIME PURCHASE/ANNUAL LICENSING MODEL, BY REGION, 2021-2028 (USD MILLION)
- BENEFITS OF LIMITED RECURRING PAYMENTS TO BOOST DEMAND
- OUTCOME /VALUE-BASED MODEL
- RESULT-DRIVEN APPROACH THAT ENHANCES END-USER ENGAGEMENT TO PROPEL MARKET
- Table DIGITAL THERAPEUTICS MARKET FOR OUTCOME/VALUE-BASED MODEL, BY REGION, 2021-2028 (USD MILLION)
- RESULT-DRIVEN APPROACH THAT ENHANCES END-USER ENGAGEMENT TO PROPEL MARKET
- INTRODUCTION
- DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
- INTRODUCTION
- Table DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- B2B SALES CHANNEL
- Table DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY REGION, 2021-2028 (USD MILLION)
- PAYERS
- Table DIGITAL THERAPEUTICS MARKET FOR PAYERS, BY REGION, 2021-2028 (USD MILLION)
- EMPLOYERS
- Table DIGITAL THERAPEUTICS MARKET FOR EMPLOYERS, BY REGION, 2021-2028 (USD MILLION)
- PHARMACEUTICAL COMPANIES
- Table DIGITAL THERAPEUTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
- PROVIDERS
- Table DIGITAL THERAPEUTICS MARKET FOR PROVIDERS, BY REGION, 2021-2028 (USD MILLION)
- OTHER BUYERS
- Table DIGITAL THERAPEUTICS MARKET FOR OTHER BUYERS, BY REGION, 2021-2028 (USD MILLION)
- B2C SALES CHANNEL
- Table DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY REGION, 2021-2028 (USD MILLION)
- CAREGIVERS
- Table DIGITAL THERAPEUTICS MARKET FOR CAREGIVERS, BY REGION, 2021-2028 (USD MILLION)
- PATIENTS
- Table DIGITAL THERAPEUTICS MARKET FOR PATIENTS, BY REGION, 2021-2028 (USD MILLION)
- INTRODUCTION
- DIGITAL THERAPEUTICS MARKET, BY REGION
- INTRODUCTION
- Table DIGITAL THERAPEUTICS MARKET, BY REGION, 2021-2028 (USD MILLION)
- NORTH AMERICA
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- NORTH AMERICA: RECESSION IMPACT
- US
- Table US: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table US: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- CANADA
- Table CANADA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table CANADA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- EUROPE
- Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- EUROPE: RECESSION IMPACT
- GERMANY
- Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- UK
- Table UK: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table UK: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- FRANCE
- Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- SPAIN
- Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- ITALY
- Table ITALY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table ITALY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- REST OF EUROPE
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- ASIA PACIFIC
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- ASIA PACIFIC: RECESSION IMPACT
- JAPAN
- Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- CHINA
- Table CHINA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table CHINA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- INDIA
- Table INDIA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table INDIA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- REST OF ASIA PACIFIC
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- LATIN AMERICA
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- LATIN AMERICA: RECESSION IMPACT
- BRAZIL
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- MEXICO
- Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- REST OF LATIN AMERICA
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- MIDDLE EAST & AFRICA
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- MIDDLE EAST & AFRICA: RECESSION IMPACT
- GCC COUNTRIES
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- REST OF MIDDLE EAST & AFRICA
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
- INTRODUCTION
- COMPETITIVE LANDSCAPE
- OVERVIEW
- KEY PLAYER STRATEGIES
- REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
- REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL THERAPEUTICS MARKET, 2020-2022 (USD MILLION)
- MARKET SHARE ANALYSIS
- Table DIGITAL THERAPEUTICS MARKET: INTENSITY OF COMPETITIVE RIVALRY
- COMPANY EVALUATION MATRIX
- STARS
- EMERGING LEADERS
- PERVASIVE PLAYERS
- PARTICIPANTS
- COMPANY FOOTPRINT
- Table DIGITAL THERAPEUTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
- Table DIGITAL THERAPEUTICS MARKET: OFFERING FOOTPRINT ANALYSIS, BY KEY PLAYER
- Table DIGITAL THERAPEUTICS MARKET: APPLICATION FOOTPRINT ANALYSIS, BY KEY PLAYER
- Table DIGITAL THERAPEUTICS MARKET: SALES CHANNEL FOOTPRINT ANALYSIS, BY KEY PLAYER
- Table DIGITAL THERAPEUTICS MARKET: REGIONAL FOOTPRINT ANALYSIS, BY KEY PLAYER
- COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
- PROGRESSIVE COMPANIES
- RESPONSIVE COMPANIES
- DYNAMIC COMPANIES
- STARTING BLOCKS
- COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- Table DETAILED LIST OF KEY STARTUPS/SMES
- Table COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
- COMPETITIVE SCENARIOS AND TRENDS
- Table DIGITAL THERAPEUTICS MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020-NOVEMBER 2023)
- DEALS
- Table DIGITAL THERAPEUTICS MARKET: DEALS (JANUARY 2020-NOVEMBER 2023)
- OTHER DEVELOPMENTS
- Table DIGITAL THERAPEUTICS MARKET: OTHER DEVELOPMENTS (JANUARY 2020-NOVEMBER 2023)
- COMPANY PROFILES
- KEY PLAYERS
- NOOM, INC.
- Table NOOM, INC.: BUSINESS OVERVIEW
- TELADOC HEALTH, INC.
- Table TELADOC HEALTH, INC.: BUSINESS OVERVIEW
- OMADA HEALTH, INC.
- Table OMADA HEALTH, INC.: BUSINESS OVERVIEW
- WELLDOC, INC.
- Table WELLDOC, INC.: BUSINESS OVERVIEW
- COGNIFIT, INC.
- Table COGNIFIT, INC.: BUSINESS OVERVIEW
- HEADSPACE HEALTH
- Table HEADSPACE HEALTH: BUSINESS OVERVIEW
- PROPELLER HEALTH
- Table PROPELLER HEALTH: BUSINESS OVERVIEW
- 2MORROW, INC.
- Table 2MORROW, INC.: BUSINESS OVERVIEW
- CANARY HEALTH
- Table CANARY HEALTH: BUSINESS OVERVIEW
- CLICK THERAPEUTICS, INC.
- Table CLICK THERAPEUTICS: BUSINESS OVERVIEW
- AKILI, INC.
- Table AKILI, INC.: BUSINESS OVERVIEW
- WELLTHY THERAPEUTICS PVT. LTD.
- Table WELLTHY THERAPEUTICS PVT. LTD.: BUSINESS OVERVIEW
- COGNOA, INC.
- Table COGNOA, INC.: BUSINESS OVERVIEW
- TWILL INC.
- Table TWILL INC.: BUSINESS OVERVIEW
- KAIA HEALTH SOFTWARE GMBH
- Table KAIA HEALTH SOFTWARE GMBH: BUSINESS OVERVIEW
- BETTER THERAPEUTICS, INC.
- Table BETTER THERAPEUTICS, INC.: BUSINESS OVERVIEW
- REALIZEDCARE
- Table REALIZEDCARE: BUSINESS OVERVIEW
- BIOFOURMIS
- Table BIOFOURMIS: BUSINESS OVERVIEW
- AYOGO INCORPORATED
- Table AYOGO INCORPORATED: BUSINESS OVERVIEW
- AMALGAM RX, INC.
- Table AMALGAM RX, INC.: BUSINESS OVERVIEW
- NOOM, INC.
- OTHER PLAYERS
- MINDABLE HEALTH GMBH
- VIRTA HEALTH CORP.
- HINGE HEALTH
- OREXO AB
- FREESPIRA, INC.
- KEY PLAYERS
- APPENDIX
- DISCUSSION GUIDE
- KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- CUSTOMIZATION OPTIONS
- RELATED REPORTS
- AUTHOR DETAILS
Market Growth Outlook Summary
The global digital therapeutics market, valued at US$4.4 billion in 2022, is forecasted to grow at a robust CAGR of 29.1%, reaching US$6.1 billion in 2023 and an impressive US$21.9 billion by 2028. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers. One of the most important factors driving growth is the integration of sophisticated digital technologies like AI/ML, wearables, mobile, etc. For instance, in 2022, Mobile Health (US) launched a fully integrated suite of digital therapeutics (DTx) solutions that offers AI-based communication to deliver evidence-based therapeutic interventions. However, lack of clear regulatory guidelines and slow reimbursement processes coupled with substantial development, maintenance, and upgrade costs pose challenge on the adoption of digital therapeutics solutions in the market.
Digital Therapeutics Market Size, Dynamics & Ecosystem
To know about the assumptions considered for the study, Request for Free Sample Report
Digital Therapeutics Market Dynamics
Drivers: Rising focus on Preventative Healthcare
Primary preventive measures can help prevent or arrest the disease in its earliest stages by promoting healthier lifestyles or immunizing against infectious diseases. Many leading causes of death and disability can be prevented with adequate measures. There is a growing consensus among policymakers, providers, and patients that preventive, behavioral, and lifestyle changes are effective pills or procedures.
In the US, chronic conditions account for ~75% of the USD 3.5-trillion annual healthcare spending (Source: chronicdisease.org and the CMS, 2019). However, these chronic diseases are largely preventable. Government legislation and initiatives, such as the Patient Protection and Affordable Care Act (PPACA) (2010), aim at making preventive care affordable and accessible. Owing to the Act, programs incentivizing preventive treatment options are becoming popular.
Restraints: Reluctance among patients to adopt digital therapeutics
Motivating people to use digital therapeutics and building their confidence is a major challenge faced by digital therapeutics providers. While older and underserved populations show maximum susceptibility to diseases and the highest occurrence rates, they are the least likely to use digital therapeutics products due to low technology literacy levels. Furthermore, the limit of how much behavioral change will be observed with digital therapeutics is still undefined.
The clinical validation and deployment of digital therapeutics are carried out on self-selected or volunteer patients; however, their effect on patients showing resistance is still unknown. Furthermore, it is unknown whether digital therapeutics can be sustained over longer periods; there is little information on total patient retention and long-term outcomes. Many patients still rely on traditional means of diagnosis and treatment and thus show reluctance to adopt these novel therapies. This poses a major challenge to the digital therapeutics market.
Opportunities: Large undiagnosed and untreated population
Despite the availability of highly effective and low-cost treatment options for chronic disorders, a large undiagnosed and untreated population still exists. According to the WHO, many people affected by chronic diseases do not get the required treatment and care. According to WHO, in 2019, over one billion people with hypertension (82% of all people with hypertension worldwide) lived in low and middle-income countries. According to BMC Public health Journal 2022, the overall prevalence rates of undiagnosed, untreated, and undertreated hypertension among older adults in India were 42.3%, 6%, and 18.7%, respectively. Approximately 90% of COPD deaths occur in low and middle-income countries, as they do not get the required treatment. Over 75% of CVD-related deaths occur in low and middle-income countries, primarily due to low/limited access to appropriate care. Often, treatment for these conditions is not integrated into primary healthcare—the only access to medical care across these regions.
Hence, the affected population is deprived of the necessary care. Other factors, such as underdeveloped health delivery systems, a lack of trained personnel, the absence of essential drugs, and the prevalence of traditional beliefs and practices, also lead to a significant untreated population. This population presents ample opportunities for the implementation of digital therapeutics. Since digital therapeutics is delivered online, it is more accessible than conventional treatment solutions and can reach more patients.
Challenges: Lack of awareness and access to digital therapeutics programs in developing countries
Healthcare information technology has witnessed significant growth in developing regions owing to healthcare reforms. However, the IT infrastructure is still inadequate to meet the demands and needs of the increasing population in these countries. Most healthcare professionals (HCPs) highlighted a lack of awareness regarding the availability and benefits of digital therapeutics.
In general, there is a lack of knowledge about the efficacy of digital therapeutics and whether these solutions have robust clinical trial data to support their use. This notion is even more prominent in markets with elevated skepticism and conservatism toward digital technology (e.g., Germany and Belgium). Digital health advancements are currently restricted primarily to economically and socially developed regions. As a result, developing regions lack awareness and access to these technological advancements in healthcare. This condition is more pronounced among the underserved populations in the rural areas of developing countries. Some common barriers include a lack of appropriate knowledge about healthcare, lack of competency for using e-health solutions, lack of digital literacy, limited or no access to the Internet, and an overall lack of awareness of digital therapeutics and its advantages.
Digital Therapeutics Market Segmentation & Geographical Spread
To know about the assumptions considered for the study, download the pdf brochure
The digital therapeutics market ecosystem comprises entities responsible for the end-to-end workflow of digital therapeutics services. The major stakeholders present in this market include network connectivity providers, infrastructure service providers, platform/service/application providers, hospitals and healthcare systems, employers, healthcare payers, government regulatory bodies and start up companies. The demand continues to grow and expand, especially after the outbreak of the COVID-19 pandemic. Solution and service providers continue to enhance and mature their offerings to add value.
Software/Platforms segment is anticipated to garner the highest share during the forecast period.
The digital therapeutics market based on offering is segmented into software/platforms, programs, and virtual reality/games. Software/Platforms is estimated to capture the largest share over the study period. This dominance is driven by the increasing reliance on sophisticated software solutions to deliver therapeutic interventions, reflecting a growing trend toward digital health solutions. The segment’s prominence highlights the crucial role of advanced technologies and platforms in shaping the trajectory of the digital therapeutics market.
Business-to-Buisness segment is anticipated to account for the lion’s share of digital therapeutics market, by Sales in 2022.
The digital therapeutics market is divided based on sales channel into business-to-business (B2B), and business-to-customer (B2C). This is owing to the increasing adoption among payers, employers, and providers understanding the benefits of digital therapeutics. Additionally, the inclination of pharmaceutical companies to incorporate digital therapeutics with their drug products is also estimated to drive the adoption of the products within these end-user segment.
Care-related/Treatment applications are the highest share of the digital therapeutics market, by applications in 2022.
The digital therapeutics market is bifurcated based on applications into care-related/treatment and preventive applications. The growth of the care-related/treatment applications segment is owed to the rising economic burden of their treatment, and investments in digital therapeutics to promote the advancement of cost-effective and scalable treatment platforms for these conditions.
North America to lead the digital therapeutics market in 2022.
The segmentation of the digital therapeutics market based on region, encompasses North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. As of 2022, North America held the dominant market share, with Europe following closely behind. The accelerated growth in North America is primarily ascribed to increased investments in digital therapeutics, improvements in the reimbursement framework for these solutions, a surge in the number of new startups in the digital therapeutics sector, and government initiatives aimed at promoting technological advancements in this region.
Key Market Players
Prominent players in digital therapeutics include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Biofourmis (US), Better Therapeutics, Inc (US), Amalgm Rx (US), CogniFit Inc (US), Headspace Health (US), Propeller Health (US), Virta Health Corp (US), 2Morrow, Inc. (US), Realizedcare (US), Canary Health (US), Twill Inc. (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Kaia Health (Germany), Ayogo (Canada), Mindable Health GmbH (Germany), Hinge Health, Inc. (US), and Freespira (US).
The research report categorizes the digital therapeutics market to forecast revenue and analyze trends in each of the following submarkets:
By Offering
- Programs
- Software/Platforms
- Virtual Reality/Games
By Revenue Modal
- Subscription
- One time Purchase/Licensing
- Outcome/Value based
By Sales Channel
- B2C
- Patients
- Caregivers
- B2B
- Providers
- Payers
- Employers
- Pharmaceutical Companies
- Other Buyers
By Application
- Preventive Applications
- Prediabetes
- Obesity
- Nutrition
- Lifestyle Management
- Other Preventive Applications
- Treatment/Care-related Applications
- Diabetes
- CNS Disorders
- Mental Health Disorder
- Other CNS Disorders
- Chronic Respiratory Disorders
- Musculoskeletal Disorders
- Cardiovascular Diseases
- Smoking Cessation
- Medication Adherence
- Gastrointestinal Disorders
- Substance Use & Addiction Management
- Rehabilitation & Patient Care
- Other Treatment/Care-related Applications
By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of the APAC
- Latin America (LATAM)
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East & Africa (MEA)
- GCC Countries
- Rest of Middle East & Africa (RoMEA)
Recent Developments
- In May 2023, Noom, Inc. announced a new program, Noom Med, designed to fight the disease of obesity. Noom Med is a program that has offers telehealth services with Noom’s personalized psychological tools for patients enrolling for weight loss.
- In May 2023, Omada Health announced a specialized program enhancement for members taking GLP-1s, in response to the growing interest and demand for the medication.
- In August 2022, Teladoc Health announced a home A1C (hemoglobin A1C) testing program for its Livongo product to help Teladoc Health members manage and control their diabetes via blood glucose meters.
- In April 2021, Welldoc (US) partnered with Dexacom (US). This partnership helped provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for improved health.
